Skip to content

Obesity hypoventilation syndrome treated with non-invasive ventilation: can we switch to CPAP?

Obesity hypoventilation syndrome treated with non-invasive ventilation: can we switch to CPAP?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00008943
Enrollment
42
Registered
2015-07-29
Start date
2015-08-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.2

Interventions

Group 1: OHS patients on succesful BiPAP therapy for at least 3 months will be switched to CPAP therapy for 4-6 weeks

Sponsors

Pneumologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Stable OHS patients on BiPAP therapy for at least 3 months considered successful as determined by diurnal PaCO2 =45 mmHg and less than 20% of total sleep time with saturation <90%. • Initial OHS diagnosis before BiPAP implementation must fulfill the conventional diagnostic criteria: coexistence of obesity (BMI =30 kg/m²) and daytime hypercapnia (PaCO2 =45 mmHg) after excluding other hypoventilation conditions. • Age = 18 years

Exclusion criteria

Exclusion criteria: • FEV1/FVC% ratio <70% plus FEV1 <50% • OHS patients on BiPAP therapy with unstable condition (= 2 hospitalizations for acute respiratory failure in the last year) • Daytime PaCO2 = 45mmHg despite established BiPAP therapy • Psychological incapacity to perform questionnaires • Refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Daytime PaCO2 measured in the morning 4 hours after ventilator removal under usual BiPAP therapy and after 4-6 weeks of CPAP therapy

Secondary

MeasureTime frame
Patients will be evaluated for their baseline data during the day and night under usual BiPAP therapy. The second measurments evaluation will take place after a 4 to 6 week period of the switch to CPAP-therapy. Parameters: - Lung function: Spirometry - Standardized six-minute walking test - Blood gases via capillary blood gas sampling - Nocturnal transcutaneous CO2 monitoring - Polysomnographic findings - Subjective sleep quality: Epworth Sleep Scale, Pittsburgh Sleep Quality Index - Health-related quality of life: Severe Respiratory Questionnaire - Ventilator’s software saved data (leckage, compliance) - Morning blood pressure (in mmHg)

Countries

Germany

Contacts

Public ContactWolfram Windisch

Pneumologie

windischw@kliniken-koeln.de0221890718929

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026